Edited by David B. Barnett, Hubert Pouleur, and Gary S. Francis. 383 pp. New York, Marcel Dekker, 1993. $135. ISBN 0-8247-8821-4.
A little more than a decade ago, a workshop on advanced congestiveheart failure was held at the National Institutes of Health.At that time, the armamentarium for treating heart failure waslimited. However, there appeared to be a consensus favoringthe use of diuretics and digoxin, and theoretical evidence supportedthe use of other agents, including vasodilators and angiotensin-converting-enzymeinhibitors. Indeed, in 1982, only 12 centers were performingcardiac transplantation, with a three-year mortality of nearly50 percent. That the past decade has been associated with anexplosion of new and novel therapies for heart failure is clearfrom . . . [Full Text of this Article]
Previous
